| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥16.2B | ¥46.8B | -65.4% |
| Operating Income | ¥-6.2B | ¥6.5B | -73.8% |
| Ordinary Income | ¥-6.1B | ¥6.8B | -72.8% |
| Net Income | ¥-5.4B | ¥4.1B | -77.7% |
| ROE | -7.3% | 5.0% | - |
FY2025 Q1-Q3 results show severe operational distress with revenue of 1.62B yen (YoY -65.4%), operating loss of -0.62B yen (deteriorated from 0.65B yen profit in prior year), ordinary loss of -0.61B yen (deteriorated from 0.68B yen profit), and net loss of -0.54B yen (deteriorated from 0.41B yen profit). The collapse in profitability stemmed from the combination of sharp revenue contraction and persistently high selling, general and administrative expenses at 0.99B yen, pushing EBIT margin to -38.3%. Despite the cash-rich balance sheet with 3.88B yen in cash and deposits providing near-term liquidity cushion, the structural deterioration in operating performance poses sustainability challenges. The full-year forecast projects continued losses with revenue of 2.55B yen (-56% YoY) and operating loss of -0.66B yen, signaling no immediate recovery in sight.
[Profitability] ROE of -7.3% reflects severe profitability erosion driven by net profit margin collapse to -33.4% (industry median 6.3%), operating margin of -38.3% (industry median 8.3%), and ROA of -6.6% (industry median 3.3%). DuPont analysis reveals the primary deterioration driver is net profit margin compression as revenue declined 65.4% while SG&A expenses remained elevated. Asset turnover of 0.197x significantly underperforms the industry median of 0.58x, indicating severe asset utilization inefficiency. Financial leverage of 1.10x remains conservative, limiting amplification of negative returns. ROIC of -14.1% indicates capital destruction, substantially below the industry median of 5.0%. [Cash Quality] Cash and deposits of 3.88B yen provide robust short-term liquidity with cash-to-short-term debt coverage of 25.84x. Current ratio of 1526.1% (industry median 2.84x) demonstrates exceptional near-term solvency, though this strength contrasts sharply with operational cash consumption. [Investment Efficiency] Asset turnover deteriorated to 0.197x versus industry median 0.58x, reflecting both revenue collapse and relative inefficiency in asset deployment. Receivables turnover extended to 316 days (industry median 83 days), indicating severe collection challenges. Inventory turnover of 66 days compares favorably to industry median of 109 days, though absolute inventory levels require monitoring given sales contraction. [Financial Health] Equity ratio of 90.8% substantially exceeds industry median of 63.8%, reflecting conservative capitalization. Current ratio of 1526.1% provides extreme liquidity buffer. Debt-to-equity ratio of 0.10x (interest-bearing debt 0.17B yen) indicates minimal leverage. However, short-term liabilities represent 89.7% of total liabilities, concentrating refinancing requirements despite low absolute debt levels.
Cash and deposits decreased 1.11B yen YoY from 4.99B yen to 3.88B yen, reflecting operational losses and working capital adjustments despite the strong absolute cash position. The cash decline occurred alongside operating losses of -0.62B yen, indicating cash consumption from core operations. Working capital efficiency showed mixed signals as accounts receivable decreased 1.11B yen YoY to 1.40B yen following revenue contraction, while accounts payable simultaneously declined 0.70B yen to 0.47B yen, suggesting reduced business activity scale. Inventory decreased 0.83B yen to 0.23B yen, representing appropriate alignment with lower sales volumes. Short-term borrowings declined sharply by 3.50B yen from 5.00B yen to 1.50B yen, indicating significant debt repayment activity that consumed cash resources alongside operational losses. Cash coverage of short-term liabilities stands at 9.71x, maintaining adequate liquidity despite the quarterly cash burn. The combination of operating losses and debt repayment explains the majority of cash decline, while the remaining 3.88B yen cash position provides runway for operational restructuring efforts.
Ordinary loss of -0.61B yen versus operating loss of -0.62B yen shows minimal non-operating contribution of approximately 0.01B yen, indicating losses are predominantly operational in nature rather than driven by one-time items. Non-operating income of 0.33B yen partially offset non-operating expenses of 0.32B yen, with the net non-operating result contributing marginally. Non-operating income represents 2.0% of revenue, a modest proportion indicating limited reliance on financial or investment income to mask operational underperformance. The gross profit margin of 22.4% remains relatively stable, suggesting pricing power or product mix has not completely deteriorated, but the inability to cover fixed SG&A expenses reveals structural cost challenges. The absence of operating cash flow statement data limits direct verification of earnings quality through accruals analysis, though the operating loss combined with cash decline suggests genuine cash-consuming operations rather than accounting distortions. Comprehensive loss of -0.74B yen exceeded net loss due to other comprehensive losses including foreign exchange impacts, adding additional shareholder value destruction beyond reported earnings.
Revenue sustainability crisis with sales declining 65.4% YoY to 1.62B yen and full-year guidance projecting 56% decline to 2.55B yen, indicating fundamental demand deterioration or customer loss requiring immediate commercial strategy revision. Customer concentration and collection risk evidenced by receivables turnover extending to 316 days versus industry median of 83 days, suggesting either problematic customer credit quality, contract disputes, or excessive dependence on specific customers with extended payment terms that strain working capital and indicate potential bad debt exposure. Operating leverage mismatch with SG&A expenses of 0.99B yen consuming 61% of revenue while generating negative operating margin of -38.3%, creating structural unprofitability where fixed cost base requires either dramatic cost reduction or minimum 2.6x revenue scale expansion to achieve breakeven, with current trajectory showing neither occurring.
[Industry Position] (Reference - Proprietary Analysis) Manufacturing sector comparison reveals significant underperformance across profitability, efficiency, and operational metrics. Profitability: ROE -7.3% versus industry median 5.0%, net profit margin -33.4% versus industry median 6.3%, operating margin -38.3% versus industry median 8.3%, and ROIC -14.1% versus industry median 5.0%, indicating the company ranks in bottom decile for returns. Financial Health: Equity ratio 90.8% substantially exceeds industry median 63.8%, and current ratio 1526.1% vastly exceeds industry median 2.84x, demonstrating exceptional balance sheet strength that contrasts with operational weakness. Efficiency: Asset turnover 0.197x significantly trails industry median 0.58x, and receivables turnover 316 days greatly exceeds industry median 83 days, revealing severe asset utilization challenges. Working capital metrics show operating WC turnover substantially worse than industry median 108 days, while inventory turnover of 66 days performs better than industry median 109 days. The substantial disconnect between strong financial position and weak operational performance suggests the company possesses financial capacity to fund turnaround efforts but faces fundamental business model or market challenges requiring strategic intervention beyond financial engineering. (Industry: Manufacturing, N=98 companies, Period: 2025-Q3, Source: Proprietary analysis)
Structural profitability crisis requiring operational transformation as the 65.4% revenue decline combined with rigid cost structure produced -38.3% operating margin, with full-year guidance showing no recovery trajectory, indicating the current business model is fundamentally unviable at present scale and requires either substantial cost rationalization reducing SG&A by approximately 60% to match revenue scale, or revenue regeneration to 2.6x current levels to absorb fixed costs, neither of which appears imminent based on disclosed forecasts. Exceptional financial fortress providing strategic optionality as 90.8% equity ratio, 3.88B yen cash position covering short-term liabilities 25.84x, and minimal 0.17B yen debt create unusual combination of operational distress with financial strength, providing management runway of approximately 6-8 quarters at current burn rate to execute turnaround through cost restructuring, business model pivot, or strategic M&A without immediate solvency pressure, though continued losses without corrective action will steadily erode this buffer. Working capital management deterioration signaling operational execution challenges as receivables collection extended to 316 days versus 83-day industry median alongside operating WC turnover substantially exceeding industry norms, suggesting either customer quality issues, contract disputes, or ineffective credit management that compounds revenue challenges by trapping cash in non-performing receivables, requiring immediate attention to collection processes and customer credit policies to release trapped capital and prevent further working capital deterioration.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.